S&P 500   2,997.05 (+0.04%)
DOW   26,783.03 (-0.02%)
QQQ   191.76 (-0.05%)
AAPL   242.44 (+1.03%)
FB   184.91 (+1.41%)
MSFT   136.14 (-0.18%)
GOOGL   1,252.34 (+0.90%)
AMZN   1,760.69 (-0.29%)
CGC   21.55 (+1.89%)
NVDA   194.26 (-0.69%)
BABA   168.45 (-0.85%)
AMD   31.30 (-0.67%)
T   37.78 (-1.02%)
NFLX   271.69 (+1.87%)
DIS   131.28 (-0.85%)
S&P 500   2,997.05 (+0.04%)
DOW   26,783.03 (-0.02%)
QQQ   191.76 (-0.05%)
AAPL   242.44 (+1.03%)
FB   184.91 (+1.41%)
MSFT   136.14 (-0.18%)
GOOGL   1,252.34 (+0.90%)
AMZN   1,760.69 (-0.29%)
CGC   21.55 (+1.89%)
NVDA   194.26 (-0.69%)
BABA   168.45 (-0.85%)
AMD   31.30 (-0.67%)
T   37.78 (-1.02%)
NFLX   271.69 (+1.87%)
DIS   131.28 (-0.85%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Ironwood PharmaceuticalsMadrigal PharmaceuticalsSupernus PharmaceuticalsCorcept TherapeuticsG1 Therapeutics
SymbolNASDAQ:IRWDNASDAQ:MDGLNASDAQ:SUPNNASDAQ:CORTNASDAQ:GTHX
Price Information
Current Price$9.24$89.68$26.62$14.09$21.59
52 Week RangeHoldBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyBuy
Consensus Price Target$15.05$177.00$54.71$15.75$62.60
% Upside from Price Target62.88% upside97.37% upside105.54% upside11.78% upside189.95% upside
Trade Information
Market Cap$1.41 billion$1.35 billion$1.39 billion$1.58 billion$784.17 million
Beta1.791.091.611.392.25
Average Volume1,314,802140,066501,891630,048616,111
Sales & Book Value
Annual Revenue$346.64 millionN/A$408.90 million$251.25 millionN/A
Price / Sales4.17N/A3.416.38N/A
CashflowN/AN/A$2.45 per share$0.66 per shareN/A
Price / CashN/AN/A10.8621.20N/A
Book Value($1.27) per share$30.99 per share$8.67 per share$2.39 per share$9.65 per share
Price / Book-7.28N/A3.075.90N/A
Profitability
Net Income$-282,370,000.00$-32,810,000.00$110.99 million$75.41 million$-85,290,000.00
EPS($0.95)($2.22)$2.05$0.60($2.56)
Trailing P/E RatioN/AN/A12.9923.48N/A
Forward P/E Ratio16.80N/A14.0114.83N/A
P/E GrowthN/AN/A$0.93N/AN/A
Net Margins-64.48%N/A25.66%29.16%N/A
Return on Equity (ROE)N/A-11.62%22.36%27.97%-28.40%
Return on Assets (ROA)-25.05%-11.38%10.52%24.84%-27.26%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.70%N/AN/A
Current Ratio1.99%38.06%2.72%7.66%18.35%
Quick Ratio1.98%38.06%2.53%7.49%18.35%
Ownership Information
Institutional Ownership PercentageN/A61.79%99.14%75.16%74.94%
Insider Ownership Percentage5.90%47.69%6.57%15.50%14.49%
Miscellaneous
Employees5151744816684
Shares Outstanding156.49 million15.43 million52.45 million113.69 million37.52 million
Next Earnings Date10/31/2019 (Confirmed)11/5/2019 (Estimated)11/5/2019 (Estimated)11/7/2019 (Estimated)11/6/2019 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
 Ironwood PharmaceuticalsMadrigal PharmaceuticalsSupernus PharmaceuticalsCorcept TherapeuticsG1 Therapeutics

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel